
New capital investments involving existing investors will bring two health care startups backed by Genesis Innovation Group closer to the market.
New capital investments involving existing investors will bring two health care startups backed by Genesis Innovation Group closer to the market.
Embody, Inc., a privately-held medical device company focused on soft tissue repair, announced that it has closed a $9.3 million Series A funding round with participation from cultivate(MD).
Embody, a cultivate(MD) portfolio company, is receiving a $2.5 million Phase II Small Business Innovation Research award through the Defense Advanced Research Projects Agency (DARPA).
Virtual Incision, a cultivate(MD) portfolio company, announced today that it has closed announced it has raised $20 million in a Series B+ financing.
A medical device startup in the region has received FDA clearance for a new product.
Genesis is proud to be a sponsor of the 2020 ASAP Meeting (Advanced Shoulder ArthroPlasty). This year’s meeting will be held on January 16-18, 2020 in Snowbird, UT.
Congratulations to Ward Detwiler, who was just awarded as a Crain’s Top 40 Under 40!
Rob Ball, CEO of Genesis Innovation Group will be a Keynote Panelist at OMTEC 2019.
HOLLAND, Mich., April 18th, 2019—Genesis Innovation Group’s Shoulder Innovations (SI) is focused on human centered design.